Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Drug:  NY-ESO-1 protein vaccine plus Montanide ISA-51 VG
Find trials that include:  Any drugs shown
Results 1-1 of 1 for your search:
Start Over
NY-ESO-1 Vaccine in Combination With Ipilimumab in Patients With Unresectable or Metastatic Melanoma
Phase: Phase I
Type: Treatment
Age: 18 and over
Trial IDs: LUD2012-004, NCI-2013-01366, NCT01810016
Start Over